Maya's Blog

When I am asked about my background in medicine I always brace myself a bit. I have had a very non traditional route to psychedelic medicine and I always fear judgement. But, I am also proud of having gone down a unique path and believe it has made me a more well-rounded healer. 

What if psychedelic-assisted therapy could be rooted in a whole-person approach of holistic care, while being supported by the type research and data found in the world of biomedicine?

Psychedelics must be used responsibly and with proper caution and this applies to the business of psychedelics as much as the molecules themselves. This is why the psychedelic medicine movement needs to prioritize a strong ethical stance, now and moving forward.

The founders of Osmind and Maya have decided to take the path less traveled and design a new paradigm for competition, which we hope can inspire others in this community. 

The demand for psychedelic therapy is increasing as people around the world look for innovative ways to improve their mental health and wellbeing. While the need for these services is growing exponentially, the infrastructure to support those on the frontlines of psychedelic healthcare hasn’t caught up.

At Maya, we know that psychedelic medicine has the power to shift the paradigm of mental healthcare on a global scale. However, the pioneers in psychedelic medicine don’t have an easy way to to demonstrate the clinical benefits of their work.